NFIB drives tumor initiation and progression in mouse models of SCLC
NFIB enhances metastasis and changes the metastatic profile
NFIB promotes dedifferentiation and invasion in SCLC
NFIB marks stage III/IV high-grade neuroendocrine carcinomas in patients